187 related articles for article (PubMed ID: 23536032)
1. [Oncologic imaging: indications for and limitations of modern cross-sectional imaging techniques].
Mayerhoefer ME; Ba-Ssalamah A; Prosch H
Radiologe; 2013 Apr; 53(4):313-21. PubMed ID: 23536032
[TBL] [Abstract][Full Text] [Related]
2. [Imaging in oncology: terms and definitions].
Brader P; Menu Y; Kreuzer S; Polanec S; Mayerhoefer M; Herold CJ
Radiologe; 2013 Apr; 53(4):303-12. PubMed ID: 23536031
[TBL] [Abstract][Full Text] [Related]
3. [Criteria for radiological assessment of therapy response: criteria-based appraisal].
D'Anastasi M; Schramm NA; Reiser MF; Graser A
Radiologe; 2013 Apr; 53(4):322-8. PubMed ID: 23553412
[TBL] [Abstract][Full Text] [Related]
4. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
5. [Whole-body MRI and FDG-PET/CT imaging diagnostics in oncology].
Schmidt GP; Haug A; Reiser MF; Rist C
Radiologe; 2010 Apr; 50(4):329-38. PubMed ID: 20229091
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.
Schiepers C; Dahlbom M
Eur Radiol; 2011 Mar; 21(3):548-54. PubMed ID: 21174096
[TBL] [Abstract][Full Text] [Related]
7. Letter to the editor re: molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.
Sauter A; Kolb A; Soekler M; Reimold M; Schwenzer N; Pfannenberg C; Claussen C; Pichler B; Horger M
Eur Radiol; 2011 Aug; 21(8):1709-12. PubMed ID: 21380639
[No Abstract] [Full Text] [Related]
8. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
[TBL] [Abstract][Full Text] [Related]
9. [Oncological imaging].
Herold C; Reiser MF; Graser A
Radiologe; 2013 Apr; 53(4):302. PubMed ID: 23549860
[No Abstract] [Full Text] [Related]
10. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
11. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.
Antoch G; Vogt FM; Freudenberg LS; Nazaradeh F; Goehde SC; Barkhausen J; Dahmen G; Bockisch A; Debatin JF; Ruehm SG
JAMA; 2003 Dec; 290(24):3199-206. PubMed ID: 14693872
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. [Combined functional and morphological imaging of sarcomas: significance for diagnostics and therapy monitoring].
Schramm N; Schlemmer M; Rist C; Issels R; Reiser MF; Berger F
Radiologe; 2010 Apr; 50(4):339-48. PubMed ID: 20221579
[TBL] [Abstract][Full Text] [Related]
14. Leading the Pack for Cancer Care.
Brink JA
J Am Coll Radiol; 2016 Sep; 13(9):1023. PubMed ID: 27593090
[No Abstract] [Full Text] [Related]
15. SPECT/CT in oncology: the fusion of two imaging modalities is a new standard of care.
Tagliabue L; Schillaci O
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):285-9. PubMed ID: 17923823
[No Abstract] [Full Text] [Related]
16. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
[TBL] [Abstract][Full Text] [Related]
17. Oncologic imaging: a guiding hand of personalized cancer care.
Hricak H
Radiology; 2011 Jun; 259(3):633-40. PubMed ID: 21493796
[No Abstract] [Full Text] [Related]
18. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
19. [Organ toxicity of medicinal tumor therapy: morphological correlates].
Sedlaczek O; Grüllich C; Röthke M; Schlemmer HP; Kauczor HU
Radiologe; 2013 Apr; 53(4):329-35. PubMed ID: 23536030
[TBL] [Abstract][Full Text] [Related]
20. Imaging in primary penile cancer: current status and future directions.
Kochhar R; Taylor B; Sangar V
Eur Radiol; 2010 Jan; 20(1):36-47. PubMed ID: 19657656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
